Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
"Edwin's outstanding experience developing successful commercial organizations in early-stage companies is a natural fit for
"I am delighted to join the
Mr. Hendrick has achieved a strong track record of building and growing businesses during a distinguished career spanning over 25 years in healthcare. He has led commercial operations within diagnostic and healthcare service companies ranging in size from
Inducement Awards
In connection with the hiring of Mr. Hendrick,
In addition, in connection with the hiring of an individual to the position of Senior Director Strategic Reimbursement and Managed Markets,
Each of the stock options described above is granted as an inducement material to entering into employment with
About
Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements as to our ability to improve the outcomes of patients diagnosed with cancer, our ability to build upon our market presence in the liquid biopsy segment, and our ability to reaccelerating sales of our Target Selector assay platform, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our
View original content to download multimedia:http://www.prnewswire.com/news-releases/biocept-names-edwin-c-hendrick-as-senior-vice-president-chief-commercial-officer-300709361.html
SOURCE
Investor Contact: LHA Investor Relations, Jody Cain, Jcain@lhai.com, 310-691-7100; Media Contact: Trevelino/Keller, Colleen Murphy, cmurphy@trevelinokeller.com, 404-214-0722, Ext. 109